Rhythm Pharmaceuticals buy Morgan Stanley
Start price
16.10.25
/
50%
€95.00
Target price
16.10.26
€110.50
Performance (%)
-15.26%
Price
11.03.26
€76.00
Summary
This prediction is currently active. The price of Rhythm Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.26%. This prediction currently runs until 16.10.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 0.641% | 0.641% |
| iShares Core DAX® | -2.526% | -5.194% |
| iShares Nasdaq 100 | -0.032% | 1.561% |
| iShares Nikkei 225® | -4.202% | -7.550% |
| iShares S&P 500 | -0.802% | 0.160% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (NASDAQ:RYTM) was given a new $129.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€100.00
11.12.25
11.12.25
-
11.12.26
11.12.26
-19.50%
11.03.26
11.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€83.00
25.09.25
25.09.25
-
25.09.26
25.09.26
-8.43%
11.03.26
11.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
8.05%
11.03.26
11.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
67.74%
08.03.26
08.03.26
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€42.40
19.12.23
19.12.23
€50.16
19.12.24
19.12.24
30.90%
20.12.24
20.12.24